Simultaneous Determination of Two Tyrosine Kinase Inhibitors in Tablets by HPLC-MS analysis

The class of tyrosine kinase inhibitors (TKIs) is represented by a group of compounds which are currently used in the treatment of different types of cancer. These oral medicines present a narrow therapeutic index and a large inter-and intra-individual variability. Within this work, a simple, accura...

Descripción completa

Detalles Bibliográficos
Autores principales: CROITORU, DANIELA MARIA, MANDA, COSTEL-VALENTIN, NEAMŢU, JOHNY, BIŢĂ, ANDREI, CROITORU, OCTAVIAN, STANCU, SOFIA TEODORA, NEAMŢU, SIMONA-DANIELA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medical University Publishing House Craiova 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289587/
https://www.ncbi.nlm.nih.gov/pubmed/35911934
http://dx.doi.org/10.12865/CHSJ.48.01.11

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289587/
https://www.ncbi.nlm.nih.gov/pubmed/35911934
http://dx.doi.org/10.12865/CHSJ.48.01.11

Ejemplares similares